Previous Article | Next Article 
Infection and Immunity, September 2002, p. 5086-5090, Vol. 70, No. 9
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.9.5086-5090.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Analysis of Serum Cross-Reactivity and Cross-Protection Elicited by Immunization with DNA Vaccines against Streptococcus pneumoniae Expressing PspA Fragments from Different Clades
Eliane N. Miyaji,1* Daniela M. Ferreira,1 Alexandre P. Y. Lopes,1 M. Cristina C. Brandileone,2 Waldely O. Dias,1 and Luciana C. C. Leite1
Centro de Biotecnologia, Instituto Butantan,1
Seção de Bacteriologia, Instituto Adolfo Lutz, São Paulo, Brazil2
Received 18 March 2002/
Returned for modification 1 May 2002/
Accepted 10 June 2002
Streptococcus pneumoniae is a major cause of disease, especially in developing countries, and cost-effective alternatives to the currently licensed vaccines are needed. We constructed DNA vaccines based on pneumococcal surface protein A (PspA), an antigen shown to induce protection against pneumococcal bacteremia. PspA fragments can be divided into three families, which can be subdivided into six clades, on the basis of PspA amino acid sequence divergence (S. K. Hollingshead, R. Becker, and D. E. Briles, Infect. Immun. 68:5889-5900, 2000). Since most clinical isolates belong to family 1 or family 2, PspA fragments from members of both of these families were analyzed. Vectors encoding the complete N-terminal regions of PspAs elicited significant humoral responses, and cross-reactivity was mainly restricted to the same family. DNA vaccines encoding fusions between PspA fragments from family 1 and family 2 were also constructed and were able to broaden the cross-reactivity, with induction of antibodies that showed reactions with members of both families. At least for the pneumococcal strains tested, the cross-reactivity of antibodies was not reflected in cross-protection. Animals immunized with DNA vaccines expressing the complete N-terminal regions of PspA fragments were protected only against intraperitoneal challenge with a strain expressing PspA from the same clade.
* Corresponding author. Mailing address: Centro de Biotecnologia, Instituto Butantan, Av. Vital Brasil, 1500, 05503-900, São Paulo, SP, Brazil. Phone: 55-11-3726-7222, ext. 2242. Fax: 55-11-3726-9150. E-mail:
enmiyaji{at}uol.com.br.
Editor: E. I. Tuomanen
Infection and Immunity, September 2002, p. 5086-5090, Vol. 70, No. 9
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.9.5086-5090.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Melin, M. M., Hollingshead, S. K., Briles, D. E., Lahdenkari, M. I., Kilpi, T. M., Kayhty, H. M.
(2008). Development of Antibodies to PspA Families 1 and 2 in Children after Exposure to Streptococcus pneumoniae. CVI
15: 1529-1535
[Abstract]
[Full Text]
-
Melin, M. M., Hollingshead, S. K., Briles, D. E., Hanage, W. P., Lahdenkari, M., Kaijalainen, T., Kilpi, T. M., Kayhty, H. M.
(2008). Distribution of Pneumococcal Surface Protein A Families 1 and 2 among Streptococcus pneumoniae Isolates from Children in Finland Who Had Acute Otitis Media or Were Nasopharyngeal Carriers. CVI
15: 1555-1563
[Abstract]
[Full Text]
-
Ferreira, D. M., Darrieux, M., Oliveira, M. L. S., Leite, L. C. C., Miyaji, E. N.
(2008). Optimized Immune Response Elicited by a DNA Vaccine Expressing Pneumococcal Surface Protein A Is Characterized by a Balanced Immunoglobulin G1 (IgG1)/IgG2a Ratio and Proinflammatory Cytokine Production. CVI
15: 499-505
[Abstract]
[Full Text]
-
Darrieux, M., Moreno, A. T., Ferreira, D. M., Pimenta, F. C., de Andrade, A. L. S. S., Lopes, A. P. Y., Leite, L. C. C., Miyaji, E. N.
(2008). Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades. J Med Microbiol
57: 273-278
[Abstract]
[Full Text]
-
Darrieux, M., Miyaji, E. N., Ferreira, D. M., Lopes, L. M., Lopes, A. P. Y., Ren, B., Briles, D. E., Hollingshead, S. K., Leite, L. C. C.
(2007). Fusion Proteins Containing Family 1 and Family 2 PspA Fragments Elicit Protection against Streptococcus pneumoniae That Correlates with Antibody-Mediated Enhancement of Complement Deposition. Infect. Immun.
75: 5930-5938
[Abstract]
[Full Text]
-
Ferreira, D. M., Miyaji, E. N., Oliveira, M. L. S., Darrieux, M., Areas, A. P. M., Ho, P. L., Leite, L. C. C.
(2006). DNA vaccines expressing pneumococcal surface protein A (PspA) elicit protection levels comparable to recombinant protein.. J Med Microbiol
55: 375-378
[Abstract]
[Full Text]
-
Li, Y., Martinez, G., Gottschalk, M., Lacouture, S., Willson, P., Dubreuil, J. D., Jacques, M., Harel, J.
(2006). Identification of a Surface Protein of Streptococcus suis and Evaluation of Its Immunogenic and Protective Capacity in Pigs. Infect. Immun.
74: 305-312
[Abstract]
[Full Text]
-
Areas, A. P. M., Oliveira, M. L. S., Miyaji, E. N., Leite, L. C. C., Ho, P. L.
(2005). Intradermal Immunization of Mice with Cholera Toxin B-Pneumococcal Surface Protein A Fusion Protein Is Protective against Intraperitoneal Challenge with Streptococcus pneumoniae. Infect. Immun.
73: 3810-3813
[Full Text]